Apomorphine
Well-documented
Well-documented
Multiple authoritative sources agree on dosing and effects.
- 2 corroborating sources
- 5 ROAs with full dose ladders
- duration data present
- 19 combo interactions documented
- PubChem toxicity data
- 2 corroborating sources
- 5 ROAs with full dose ladders
- duration data present
- 19 combo interactions documented
- PubChem toxicity data
Aliases: Apokyn, Onapgo, Apo-go, Ixense, Uprima
Summary
Apomorphine is primarily used to treat acute hypomobility episodes in advanced Parkinson's disease. Despite its name, it does not contain morphine and does not bind to opioid receptors. Nausea is extremely common; antiemetic pretreatment with trimethobenzamide or domperidone is typically required.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Subcutaneous | 1-2mg | 2-4mg | 4-8mg | 8mg+ |
| Sublingual | 10mg | - | - | - |
| Oral | 2-5mg | 5-10mg | 10-15mg | 15mg+ |
| Insufflated | 0.5-1mg | 1-2mg | 2-4mg | 4mg+ |
| Smoked | 0.5-1mg | 1-2mg | 2-4mg | 4mg+ |
| Intravenous | 1-2mg | 2-4mg | 4-8mg | 8mg+ |
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | Total |
|---|---|---|---|---|---|
| Subcutaneous | 5-15 min | 1-2 hrs | 1-2 hrs | 30-60 min | 1-2 hrs |
| Sublingual | 10-30 min | 15-30 min | 30-90 min | 30-60 min | - |
| Oral | 15-30 min | 20-40 min | 1-2 hrs | 30-60 min | 2-4 hrs |
| Insufflated | 5-15 min | 20-40 min | 1-2 hrs | 30-60 min | 3-6 hrs |
| Smoked | 1-5 min | 5-15 min | 15-30 min | 30-60 min | 1-2 hrs |
| Intravenous | 1-5 min | 5-15 min | 15-30 min | 30-60 min | 1-2 hrs |
Effect Profile
Scores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Strong anxiety/jitters with moderate stimulation, mild euphoria, low focus
Tolerance
Tolerance Decay
No robust human data on pharmacodynamic tolerance with intermittent rescue dosing; motor response may fluctuate with disease progression rather than classic tolerance. Impulse-control risks are class effects of dopamine agonists rather than tolerance phenomena.
Cross-Tolerances
Effects
- Relief of Parkinsonian symptoms
- Stimulation
- Nausea
- Vomiting
- Increased heart rate
- Vasoconstriction
- Insomnia
- Yawning
- Orthostatic hypotension
- Sudden sleep onset
- Alertness enhancement
- Euphoria
- Wakefulness
- Motivation enhancement
- Drowsiness
- Dizziness
- Anxiety
- Compulsive behaviors
- Talkativeness
- Time distortion
- Increased music appreciation
- Increased libido
- Tactile enhancement
- Color enhancement
- Light sensitivity
- Appetite suppression
- Dehydration
- Disinhibition
- Hallucinations
- Drifting
Combinations
Cross-Check Apomorphine with another substancePill Identifiers
Helpful Links
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for Apomorphine? Let us know. Reports are reviewed by moderators — this is not posted publicly.